journal
https://read.qxmd.com/read/38616700/sickle-cell-disease-today-a-75-year-journey-from-first-molecular-disease-to-first-gene-editing-therapy
#1
JOURNAL ARTICLE
Marc Schapira, Mark J Koury, Irene Roberts
No abstract text is available yet for this article.
April 10, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38635904/pharmacometric-in-silico-studies-used-to-facilitate-a-national-dose-standardisation-process-in-neonatology-application-to-amikacin
#2
JOURNAL ARTICLE
Verena Gotta, Julia Anna Bielicki, Paolo Paioni, Chantal Csajka, Dominic Stefan Bräm, Christoph Berger, Elisabeth Giger, Michael Buettcher, Klara M Posfay-Barbe, John Van den Anker, Marc Pfister
BACKGROUND AND AIMS: Pharmacometric in silico approaches are frequently applied to guide decisions concerning dosage regimes during the development of new medicines. We aimed to demonstrate how such pharmacometric modelling and simulation can provide a scientific rationale for optimising drug doses in the context of the Swiss national dose standardisation project in paediatrics using amikacin as a case study. METHODS: Amikacin neonatal dosage is stratified by post-menstrual age (PMA) and post-natal age (PNA) in Switzerland and many other countries...
April 8, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38587784/exploring-viral-aetiology-in-upper-respiratory-tract-infections-insights-from-metagenomic-next-generation-sequencing-in-swiss-outpatients-before-and-during-the-sars-cov-2-pandemic
#3
JOURNAL ARTICLE
Verena Kufner, Andrea C Frey, Sara H Burkhard, Stefan Schmutz, Gabriela Ziltener, Maryam Zaheri, Caroline V Wiedmer, Andreas Plate, Alexandra Trkola, Michael Huber, Nicolas J Mueller
AIMS OF THE STUDY: Upper respiratory tract infections are among the most common reasons for primary care consultations. They are diagnosed predominantly based on clinical assessment. Here, we investigated the benefit of viral metagenomic next-generation sequencing (mNGS) in an outpatient setting. METHODS: This prospective cross-sectional study included immunocompetent patients with acute upper respiratory tract infections. General practitioners collected pharyngeal swabs and demographic and clinical data...
April 5, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579301/transdisciplinary-sarcoma-care-a-model-for-sustainable-healthcare-transformation
#4
JOURNAL ARTICLE
Bruno Fuchs, Beata Bode, Philip Heesen, Barbara Kopf, Christian Michelitsch, Manfred Odermatt, Pietro Giovanoli, Stefan Breitenstein, Paul Schneider, Guido Schüpfer, Stefan Boes, Gabriela Studer
No abstract text is available yet for this article.
April 4, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579300/an-in-hospital-intervention-to-reduce-the-proportion-of-misused-inhalers-at-hospital-discharge-among-patients-with-copd-a-non-randomised-intervention-study
#5
JOURNAL ARTICLE
Gael Grandmaison, Thomas Grobéty, Philippe Dumont, Julien Vaucher, Daniel Hayoz, Philipp Suter
AIMS OF THE STUDY: Misuse of inhalers during chronic obstructive pulmonary disease (COPD) treatment is common and may result from errors in inhalation technique or insufficient peak inspiratory flow (PIF). We aimed to evaluate the impact of an in-hospital intervention to reduce inhaler misuse at hospital discharge among patients with COPD. METHODS: We conducted a monocentric, non-randomised intervention study to compare the proportion of misused inhalers at hospital discharge by patients with COPD between a group with standard care and a group receiving an in-hospital intervention...
April 4, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579327/genomic-characteristics-of-clinical-non-toxigenic-vibrio-cholerae-isolates-in-switzerland-a-cross-sectional-study
#6
JOURNAL ARTICLE
Natalie Meyer, Roger Stephan, Nicole Cernela, Jule Anna Horlbog, Michael Biggel
STUDY AIMS: Although non-toxigenic Vibrio cholerae lack the ctxAB genes encoding cholera toxin, they can cause diarrhoeal disease and outbreaks in humans. In Switzerland, V. cholerae is a notifiable pathogen and all clinical isolates are analysed at the National Reference Laboratory for Enteropathogenic Bacteria and Listeria. Up to 20 infections are reported annually. In this study, we investigated the population structure and genetic characteristics of non-toxigenic V...
April 2, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579294/lipoprotein-a-as-a-blood-marker-for-large-artery-atherosclerosis-stroke-etiology-validation-in-a-prospective-cohort-from-a-swiss-stroke-center
#7
JOURNAL ARTICLE
Salome Rudin, Lilian Kriemler, Tolga D Dittrich, Annaelle Zietz, Juliane Schweizer, Markus Arnold, Nils Peters, Filip Barinka, Simon Jung, Marcel Arnold, Urs Fischer, Katharina Rentsch, Mirjam Christ-Crain, Mira Katan, Gian Marco De Marchis
BACKGROUND: Lipoprotein (a) [Lp(a)] serum levels are highly genetically determined and promote atherogenesis. High Lp(a) levels are associated with increased cardiovascular morbidity. Serum Lp(a) levels have recently been associated with large artery atherosclerosis (LAA) stroke. We aimed to externally validate this association in an independent cohort. METHODS: This study stems from the prospective multicentre CoRisk study (CoPeptin for Risk Stratification in Acute Stroke patients [NCT00878813]), conducted at the University Hospital Bern, Switzerland, between 2009 and 2011, in which Lp(a) plasma levels were measured within the first 24 hours after stroke onset...
April 2, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38642364/incidence-and-outcomes-of-emergency-department-patients-requiring-emergency-general-surgery-a-5-year-retrospective-cohort-study
#8
JOURNAL ARTICLE
Christophe A Fehlmann, Monica Taljaard, Daniel I McIssac, Laurent Suppan, Elisabeth Andereggen, Arnaud Dupuis, Frederic Rouyer, Debra Eagles, Jeffrey J Perry
AIMS: Patients undergoing emergency general surgery are at high risk of complications and death. Our objectives were to estimate the incidence of emergency general surgery in a Swiss University Hospital, to describe the characteristics and outcomes of patients undergoing such procedures, and to study the impact of age on clinical outcomes. METHODS: This was a retrospective cohort study of adult patients who visited the emergency department (ED) of Geneva University Hospitals between January 2015 and December 2019...
April 1, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38642026/core-stories-of-physicians-on-a-swiss-internal-medicine-ward-during-the-first-covid-19-wave-a-qualitative-exploration
#9
JOURNAL ARTICLE
Vanessa Kraege, Amaelle Gavin, Julieta Norambuena, Friedrich Stiefel, Marie Méan, Céline Bourquin
INTRODUCTION: The first COVID-19 wave (2020), W1, will remain extraordinary due to its novelty and the uncertainty on how to handle the pandemic. To understand what physicians went through, we collected narratives of frontline physicians working in a Swiss university hospital during W1. METHODS: Physicians in the Division of Internal Medicine of Lausanne University Hospital (CHUV) were invited to send anonymous narratives to an online platform, between 28 April and 30 June 2020...
March 29, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38639178/impact-of-shift-work-and-other-work-related-factors-on-anti-sars-cov-2-spike-protein-serum-concentrations-in-healthcare-workers-after-primary-mrna-vaccination-a-retrospective-cohort-study
#10
JOURNAL ARTICLE
Gianluca Mauro Menghini, Robert Thurnheer, Christian R Kahlert, Philipp Kohler, Fabian Grässli, Reto Stocker, Manuel Battegay, Danielle Vuichard-Gysin
BACKGROUND: Knowing whether shift work negatively affects the immune system's response to COVID-19 vaccinations could be valuable for planning future vaccination campaigns for healthcare workers. We aimed to determine the impact of working late or night shifts on serum anti-SARS-CoV-2 spike protein immunoglobulin G (anti-S) antibody levels after primary SARS-CoV-2-mRNA vaccination. METHODS: To obtain detailed information on shift work, we sent a separate online questionnaire to 1475 eligible healthcare workers who participated in a prospective longitudinal study conducted in 15 healthcare institutions in Switzerland...
March 27, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579310/investigations-of-an-increased-incidence-of-non-aspergillus-invasive-mould-infections-in-an-onco-haematology-unit
#11
JOURNAL ARTICLE
Elisavet Stavropoulou, Anne Huguenin, Giorgia Caruana, Onya Opota, Nancy Perrottet, Dominique S Blanc, Bruno Grandbastien, Laurence Senn, Pierre-Yves Bochud, Frederic Lamoth
AIMS OF THE STUDY: Invasive mould infections are life-threatening complications in patients with haematologic cancer and chemotherapy-induced neutropenia. While invasive aspergillosis represents the main cause of invasive mould infections, non-Aspergillus mould infections, such as mucormycosis, are increasingly reported. Consequently, their local epidemiology should be closely monitored. The aim of this study was to investigate the causes of an increased incidence of non-Aspergillus mould infections in the onco-haematology unit of a Swiss tertiary care hospital...
March 26, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579290/impact-on-diabetes-control-and-patient-reported-outcomes-of-a-newer-implantable-continuous-glucose-monitoring-system-eversense%C3%A2-cgm-system-a-single-centre-retro-and-prospective-observational-study
#12
JOURNAL ARTICLE
Dimitri Guy Rohner, Lukas Burget, Christoph Henzen, Stefan Fischli
AIMS OF THE STUDY: The Eversense® CGM System is the first and only continuous glucose monitoring system (CGMS) that uses a fully subcutaneous implanted sensor. This study aimed to evaluate effectiveness, safety and patient-reported outcomes in patients using the Eversense® CGM System in a realistic clinical setting, assessed at a single Swiss diabetes centre (Luzerner Kantonsspital) with prolonged follow-up. METHODS: This was a prospective and retrospective observational study that included patients with type 1 diabetes mellitus in whom at least one Eversense® glucose sensor was implanted between 2017 and 2022...
March 20, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579312/a-cohort-study-of-patients-hospitalised-with-sars-cov-2-infection-in-ontario-patient-characteristics-and-outcomes-by-wave
#13
JOURNAL ARTICLE
Steven Habbous, Anna Lambrinos, Kirsten Ming, Erik Hellsten
INTRODUCTION: Each wave of the COVID-19 pandemic exhibited a unique combination of epidemiological, social and structural characteristics. We explore similarities and differences in wave-over-wave characteristics of patients hospitalised with COVID-19. METHODS: This was a population-based study in Ontario province, Canada. Patients hospitalised with SARS-CoV-2 between 26 February 2020 and 31 March 2022 were included. An admission was considered related to SARS-CoV-2 infection if the provincial inpatient or outpatient hospital databases contained the ICD-10 diagnostic codes U071/U072 or the Ontario Laboratories Information System indicated a positive SARS-CoV-2 test result (PCR or rapid antigen testing) during the admission or up to two weeks prior...
March 13, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38642339/association-between-the-number-of-symptomatic-mpox-cases-and-the-detection-of-mpox-virus-dna-in-wastewater-in-switzerland-an-observational-surveillance-study
#14
JOURNAL ARTICLE
Claudia Bagutti, Monica Alt Hug, Philippe Heim, Evelyn Ilg Hampe, Philipp Hübner, Timothy R Julian, Katrin N Koch, Kerstin Grosheintz, Melanie Kraus, Carla Schaubhut, Rahel Tarnutzer, Eva Würfel, Simon Fuchs, Sarah Tschudin-Sutter
AIM OF THE STUDY: The COVID-19 pandemic has drawn attention to the benefit of wastewater-based epidemiology, particularly when case numbers are underreported. Underreporting may be an issue with mpox, where biological reasons and stigma may prevent patients from getting tested. Therefore, we aimed to assess the validity of wastewater surveillance for monitoring mpox virus DNA in wastewater of a Central European city and its association with official case numbers. METHODS: Wastewater samples were collected between 1 July and 28 August 2022 in the catchment area of Basel, Switzerland, and the number of mpox virus genome copies they contained was determined by real-time quantitative PCR...
March 7, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579313/evaluation-of-a-surveillance-system-for-clostridioides-difficile-infections-for-swiss-hospitals
#15
JOURNAL ARTICLE
Ana Durovic, Alexandra Ursula Scherrer, David Widmer, Andreas F Widmer
AIMS: This study evaluated an approach to establishing a comprehensive nationwide surveillance system for Clostridioides difficile infection in Switzerland. We report the results of patient-related surveillance and calculate the incidence rate of C. difficile infection in Switzerland in 2022. METHODS: Initiated in 2017 by the National Centre for Infection Prevention (Swissnoso), in collaboration with the Swiss Centre for Antibiotic Resistance (ANRESIS), laboratory surveillance enables the automatic import of C...
March 5, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579331/introducing-opt-out-organ-donation-in-switzerland-lessons-from-the-uk-experience
#16
JOURNAL ARTICLE
Jordan A Parsons
No abstract text is available yet for this article.
March 4, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579321/use-of-unlicensed-drugs-in-a-swiss-pediatric-university-hospital-and-associated-prescribing-error-rates-a-retrospective-observational-study
#17
JOURNAL ARTICLE
Aylin Satir, Miriam Pfiffner, Christoph R Meier, Angela Caduff Good
AIMS OF THE STUDY: Unlicensed drugs are frequently used in paediatric care. To what extent they are prescribed in hospital care in Switzerland is unclear. Because prescribing errors seem to occur more frequently with unlicensed drugs, we aimed to assess the prevalence of unlicensed drug prescriptions in two study periods (2018 and 2019) at the University Children's Hospital Zurich, compare these periods and investigate whether unlicensed drugs were more prone to prescribing errors than licensed drugs...
March 4, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579289/pembrolizumab-associated-anti-mda5-dermatomyositis-in-a-patient-with-lung-cancer-a-first-case-report
#18
JOURNAL ARTICLE
Antonino Marcello Pilia, Lorenzo Salvati, Alessia Guidolin, Francesca Mazzoni, Lorenzo Antonuzzo, Paola Parronchi, Francesco Liotta
We report the first case of anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis as a systemic immune-related adverse event in a 64-year-old man receiving pembrolizumab to treat advanced lung cancer. The patient experienced hypothyroidism, myalgia, skin involvement, dyspnoea and diarrhoea. Laboratory tests revealed raised inflammatory markers, hypercreatinekinasemia and anti-MDA5 autoantibodies. Electroneuromyography and pathognomonic signs on physical examination confirmed the diagnosis of pauci-myopathic dermatomyositis...
March 4, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579293/hepatitis-c-prevalence-and-cascade-of-care-among-patients-in-the-decentralised-opioid-agonist-therapy-programme-of-the-canton-of-st-gallen-switzerland-a-cross-sectional-study
#19
JOURNAL ARTICLE
Kerstin Wissel, Pietro Vernazza, Stefan Kuster, Katharina Hensel-Koch, Andrea Bregenzer
BACKGROUND: To eliminate chronic hepatitis C virus (HCV) infection by 2030, 90% of those infected must be diagnosed and 80% treated. In Switzerland, >40% of the estimated 32,000 infected people are still undiagnosed. In the canton of St Gallen, HCV prevalence and cascade of care have only been studied in the centralised opioid agonist therapy (OAT) setting (institutions), although about 80% of OAT patients are treated decentrally (general practitioner [GP] or pharmacy). AIM: To describe HCV prevalence and cascade of care among patients in the decentralised OAT programme of the canton of St Gallen, Switzerland, and compare it to contemporaneous data from the centralised setting...
February 29, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579297/the-magnitude-of-the-plasma-hepcidin-response-to-oral-iron-supplements-depends-on-the-iron-dosage
#20
JOURNAL ARTICLE
Maximilian Karczewski, Stana Simic, Lanja Saleh, Albina Nowak, Morton G Schubert, Diego Moretti, Dorine W Swinkels, Felix Beuschlein, Paolo M Suter, Pierre-Alexandre Krayenbuehl
BACKGROUND: Iron deficiency without anaemia is a common health problem, especially in young menstruating women. The efficacy of the usually recommended oral iron supplementation is limited due to increased plasma hepcidin concentration, which reduces iron absorption and leads to side effects such as intestinal irritation. This observation raises the question of how low-dose iron therapy may affect plasma hepcidin levels and whether oral iron intake dose-dependently affects plasma hepcidin production...
February 19, 2024: Swiss Medical Weekly
journal
journal
37164
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.